Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment (NCT05711056)
Expanding Rural Access to Opioid Use Disorder Treatment Utilizing Medical Toxicologists and the Georgia Poison Center to Facilitate Emergency Department- and Telehealth-Based Medication Initiation and Linkage to Care
🩺 Plain-English Summary (8th-Grade Level)
The overarching goal of this project is to increase the availability of OUD treatment in rural counties in the state of Georgia by using Emergency Department (ED)-based telehealth strategies to initiate MOUD and connect patients to treatment. The investigators will implement a novel collaboration between rural EDs, medical toxicologists at the Georgia Poison Center (GPC), peer recovery coaches (PRCs) and RCOs throughout Georgia to bridge the gap between OUD treatment need in rural EDs and specialty physician availability at the GPC. Research activities will be conducted during two broad phases, at three rural EDs in Georgia: planning and implementation. During the planning phase, aggregate data will be obtained to determine each ED's existing practices treating patients with OUD and opioid withdrawal. During the implementation phase, the researchers will prospectively study a poison center OUD consultation and PRC intervention as it is rolled out at each site, collecting participant-level data. Sites will be rolled into the implementation phase in a stepped-wedge fashion, so there will be times when some sites are in the planning phase while others are in the implementation phase.
Who can join: Review the eligibility criteria below.
Location: Georgia Poison Center — Atlanta, Georgia
Age range: 18 Years
🧪 Interventions in This Study
- Sociobehavioral Intervention (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Georgia Poison Center — Atlanta, Georgia
📞 Contact the Study Coordinator
Phone: (412) 519-4944
Email: emily.anne.kiernan@emory.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Use
- Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse — Raleigh, North Carolina
- Treating Polysubstance Use Using a Novel Digital Technology — Baltimore, Maryland
- Opioid Analgesic Reduction Study — Chicago, Illinois
- Patient Utilization of Opioid Destruction Bags in the Post-op Period — Omaha, Nebraska
- Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure — Chicago, Illinois
- SLeep and OPioid UsE in Patients Undergoing Total Knee Arthroplasty — La Jolla, California
Explore by condition: All Opioid Use clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.